diabetes,GLP1,MedTwitter

Mashup Score: 15

Quantifying Benefits and Risks of GLP-1–Receptor Agonists for Patients with Diabetes - 2 month(s) ago

The glucagon-like peptide-1 (GLP-1)–receptor agonist drugs, developed to treat patients with diabetes, also deliver many additional benefits. In a very

Source: www.jwatch.org

Categories: General Medicine News

Tweet Tweets with this article
- JWatch
  
  In a very large study, GLP-1 agonists lowered risk for many diseases that are not related to diabetes. https://t.co/ICEjKNJxyg #diabetes #GLP1 #MedTwitter https://t.co/UfO95R23XJ